Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response

Xiaolei Wang1,2, Terrence Tsz-Tai Yuen3, Ying Dou1

  • 1School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.

Nature Communications
|June 10, 2023
PubMed

Insights

The mRNA vaccine BNT162b2 provides protection against COVID-19 variants by inducing cellular immunity. This cellular immunity, marked by interferon-gamma production, is crucial for protection when antibody immunity is evaded.

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • COVID-19 pandemic control relies on mass vaccination.
  • SARS-CoV-2 Omicron variants evade immunity from vaccination or prior infection.
  • The role of cellular immunity against immune-evasive variants requires investigation.

Purpose of the Study:

  • To determine if the mRNA vaccine BNT162b2 induces anti-viral cellular immunity against SARS-CoV-2 variants.
  • To assess the protective efficacy of BNT162b2 in a model lacking humoral immunity.
  • To investigate the contribution of cellular immunity to protection against Omicron sub-variants.

Main Methods:

  • Utilized K18-hACE2 transgenic B-cell deficient (μMT) mice.
  • Administered the mRNA vaccine BNT162b2 to mice.
  • Challenged vaccinated mice with SARS-CoV-2 Omicron BA.1 and BA.5.2 sub-variants.
  • Assessed cellular immunity, focusing on Interferon-gamma (IFN-γ) production.

Main Results:

  • BNT162b2 vaccination conferred robust protective immunity in μMT mice.
  • Protection was attributed to cellular immunity, evidenced by significant IFN-γ production.
  • Vaccinated μMT mice showed boosted cellular responses upon challenge with Omicron BA.1 and BA.5.2.

Conclusions:

  • The mRNA vaccine BNT162b2 induces significant protective immunity independent of antibody production.
  • Cellular immunity plays a critical role in combating SARS-CoV-2 variants that evade humoral immunity.
  • These findings underscore the importance of cellular immunity in the context of evolving SARS-CoV-2 variants.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
830
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
69.1K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
694
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
999
Vaccinations01:51

Vaccinations

Overview
44.8K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
73.3K